@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-ZLVW9ZNS-Q mesh:allowableQualifier jvr:-M63HSDM7-1, jvr:-T9HQD7ST-J, jvr:-G4R176S9-J, jvr:-S0CS1X5R-5, jvr:-W6SQV79N-S, jvr:-CB30NGKB-3, jvr:-G30ZJ446-J, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-Q3979798-W, jvr:-WK5F724J-1, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-THHNVC7V-3, jvr:-XV06LPML-W, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-TJHVZCRZ-0, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-NHL3D2X0-S, jvr:-H7K65Q8S-Z, jvr:-NFTHND7Q-8, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R ; skos:hiddenLabel "Dipotassium Glycyrrhizinate"@en, "Glycyrrhizinate zincique"@fr, "Glycyrrhizinate de diammonium"@fr, "Glycyrrhizinate de dipotassium"@fr, "Diammonium Glycyrrhizinate"@en, "Glycyrrhizinate dipotassique"@fr, "Zinc Glycyrrhizate"@en, "Glycyrrhizinate de zinc"@fr ; skos:altLabel "CA2Y0FE3FX"@fr, "CA2Y0FE3FX"@en, "6FO62043WK"@fr, "6FO62043WK"@en, "1405-86-3 (Glycyrrhizic Acid)"@fr, "1405-86-3 (Glycyrrhizic Acid)"@en, "Glycyrrhizine"@fr, "Glycyrrhizinic Acid"@en, "alpha-D-glucopyranosiduronic acid, (3 beta,20 beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-"@en, "alpha-D-glucopyranosiduronic acid, (3 beta,20 beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-"@fr, "Glycyrrhizin"@en ; dc:modified "2013-07-08"^^xsd:date ; skos:prefLabel "Glycyrrhizic Acid"@en, "Acide glycyrrhizique"@fr ; skos:inScheme jvr: ; mesh:pharmacologicalAction jvr:-FW3F2V3X-Z ; owl:sameAs ; a skos:Concept, mesh:Descriptor ; dc:created "1997-06-20"^^xsd:date ; dc:established "1998-01-01"^^xsd:date ; skos:definition "A widely used anti-inflammatory agent isolated from the licorice root. It is metabolized to GLYCYRRHETINIC ACID, which inhibits 11-BETA-HYDROXYSTEROID DEHYDROGENASES and other enzymes involved in the metabolism of CORTICOSTEROIDS. Therefore, glycyrrhizic acid, which is the main and sweet component of licorice, has been investigated for its ability to cause hypermineralocorticoidism with sodium retention and potassium loss, edema, increased blood pressure, as well as depression of the renin-angiotensin-aldosterone system."@en ; skos:broader jvr:-JGKQGQK7-N . jvr:-JGKQGQK7-N skos:prefLabel "Pentacyclic Triterpenes"@en, "Triterpènes pentacycliques"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZLVW9ZNS-Q . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-FW3F2V3X-Z skos:prefLabel "Anti-inflammatoires"@fr, "Anti-Inflammatory Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .